Circulating innate and adaptive immunity against anti-Haemophilus influenzae type b.

Authors:
Mustafa H Linjawi
Mustafa H Linjawi
King Abdulaziz University
Saudi Arabia
Elrashdy M Redwan
Elrashdy M Redwan
Genetic Engineering and Biotechnology Research Institute
Egypt

Hum Antibodies 2019 Mar 22. Epub 2019 Mar 22.

Biological Sciences Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.

Haemophilus influenzae type b (Hib) are one of most dangerous microbes that occupies the paediatric nasopharyngeal as a commensal opportunistic bacterium, which may lead to meningitis in uncontrolled infection. Colonisation of pharyngeal tissues is the starting point for most H. influenzae infections, which may develop into invasive diseases, such meningitis. The vaccination against Hib in specific, as well as against most of vaccines preventable diseases; in general, play a major role in reducing children (< 5 years old) Hib meningitis from 57/100,000 to the lowest known Hib meningitis incidents in the history. First invented Hib vaccine was licensed in 1985 and contained Hib capsular polysaccharide (CPS); afterward, conjugate vaccines have been innovated and licensed on the road to improve Hib vaccine efficacy. Polyribosylribitol phosphate (PRP) is the main vaccine unite structure. Since anti-CPS antibodies in the serum reflect the extent of the acquired immunity against Hib infections, the concentration of ⩾ 0.15 g/ml of anti-CPS is believed to be an indicator for short-term protection from invasive Hib diseases, whereas one-month post-completion of primary Hib immunization concentration of ⩾ 1.0 g/ml is trusted to be immunological protective. As considered that serum anti-CPS antibodies are effectively linked to protection, the evaluation of antibodies concentration and reconsideration of published worldwide populations antibodies concentration are consider vital strides on the way to accurate valuation of Hib immunity that induced by vaccination; either direct or herd. As documented, some populations; worldwide, still susceptible to invasive Hib infections. Several populations worldwide remain vulnerable to Hib-related infections. We believe that up-to-date review article regarding circulated Hib immunology, represented in anti-Hib antibodies and worldwide Hib incidences will provide a precious information for microbiologists, public health officials, epidemiologists, immunologists, and strategic preventive healthcare executives.

Download full-text PDF

Source
http://dx.doi.org/10.3233/HAB-190373DOI Listing
March 2019
7 Reads

Publication Analysis

Top Keywords

hib
14
influenzae type
8
anti-cps antibodies
8
concentration ⩾
8
hib infections
8
invasive hib
8
hib vaccine
8
populations worldwide
8
hib meningitis
8
antibodies concentration
8
antibodies
5
afterward conjugate
4
worldwide
4
conjugate vaccines
4
concentration consider
4
cps afterward
4
consider vital
4
efficacy polyribosylribitol
4
populations antibodies
4
vaccines innovated
4

References

(Supplied by CrossRef)
Update on Routine Childhood and Adolescent Immunizations
Ackerman et al.
Am Fam Physician 2015
Conjugated pneumococcal vaccine for children in saudi arabia: Following the footsteps of hib vaccine
Al-Zamil et al.
J Egypt Public Health Assoc 2008

Similar Publications